Please login to the form below
Opioid epidemic
This page shows the latest Opioid epidemic news and features for those working in and with pharma, biotech and healthcare.
US states claim Purdue Pharma owes $2.2 trillion over opioid crisis
Last year, Purdue filed for bankruptcy following increasing blame for its part in driving the opioid epidemic in the US. ... well as millions of doses of lifesaving opioid addiction treatment and overdose reversal medicines,” Purdue said in a statement.
Latest news
-
US piles pressure on Mallinckrodt over alleged Acthar fraud
settle claims that it had a hand in fuelling the opioid epidemic in the US.
-
Mallinckrodt reaches tentative $1.6bn opioid settlement
Agreement reached with a plaintiff's executive committee. Mallinckrodt, one of the companies at the centre of the opioid epidemic scandal in the US, has reached a tentative settlement agreement in ... We recognise the opioid crisis is a tremendously
-
US states reject drug distributors’ opioid settlement
At least 21 US states have rejected an $18bn proposal by the ‘big three’ pharma wholesalers to settle opioid litigation, according to a Wall Street Journal report. ... to negotiating a deal that would “provide relief to communities impacted by the
-
Presidential hopeful Bernie Sanders criticises BioMarin’s gene therapy price
The bad reputation was attributed to, most notably, the ongoing opioid litigation against a number of pharma companies and ongoing scrutiny over medicine prices. ... According to Gallup: “The industry's rating likely will not recover until its role in
-
FDA committee rejects Intellipharmaceutics’ opioid drug Aximris
Oxycodone is the active ingredient of recently bankrupted Purdue Pharma’s OxyContin, a drug which had taken much of the brunt of blame for the opioid addiction epidemic in the US. ... abuse. A number of pharma companies in the US have recently faced
More from news
Approximately 13 fully matching, plus 15 partially matching documents found.
Latest Intelligence
-
20 for 2020 – Five pharma leaders to watch in 2020
Hahn is taking over as the FDA is being thrust into the spotlight on a number of issues, including how to deal with medicine prices, the opioid epidemic, hastening access to
-
20 for 2020 – Five pharma companies to watch
year. We’re talking about the lawsuits J&J is facing claiming damages as a result of using its products, including opioid painkillers, Baby Powder talc and its schizophrenia drug Risperdal ... epidemic in opioid abuse and overdose-related deaths in the
-
Trust: the ultimate elevator
This is particularly apparent for the traditional ‘big pharma’ sector – shaken by scandals such as pricing, manipulative patent litigation and a rampant opioid epidemic.
-
How digital content helps HCPs curb opioid abuse through better prescribing decisions
opioid abuse epidemic. ... The pain management topic found under most specialties at Univadis highlights curated synopses of the best literature dealing with the opioid abuse epidemic, including an overview of 12 predictors of patient
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
"Legal highs" ruling leaves illegal labs laughing
So we are acutely aware of the devastation caused by the opioid epidemic in the US, and the criticism aimed at Purdue, the maker of OxyContin. . ... We have also pitched for agents designed to treat opioid overdose and alcohol abuse. .
-
How digital content is helping physicians curb the opioid abuse epidemic
On the other hand are the prescribers who are driven to help their patients but finding that their pain management protocols are now complicated by what the national opioid abuse epidemic ... The pain management topic found under most specialties at
-
Aptus Health
How digital content is helping physicians curb the opioid abuse epidemic.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Gilead agrees $21bn buyout of Immunomedics
- New medical communications agency BOLDSCIENCE launches
- Moderna inks R&D agreements with Vertex and Chiesi
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- FDA approves Roche’s Actemra COVID-19 trial
- OPEN Health’s Digital team have won a Bronze Award at the PM Society Digital Awards 2020
- New restrictions announced as UK’s COVID-19 alert level is increased
- Keytruda plus chemotherapy cuts risk of death by 27% in advanced oesophageal cancer
- AZ/Merck's Lynparza improves survival in certain prostate cancers
- The flexible salesforce
- Navigating engagement and remote working during the pandemic
PMHub
Aurora Healthcare Communications
We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...
Latest intelligence
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
Quick links
Infographics
